Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Patel Dinesh V Ph D sold 75,000 Protagonist Therapeutics, Inc. shares (Form 4/A)
Traded May 12, 2026 · Filed May 14, 2026
On May 12, 2026, Patel Dinesh V Ph D (Director, President and CEO) sold 75,000 Protagonist Therapeutics, Inc. shares at US$100.12 for US$7.51M under a trading plan, leaving 523,478 shares. Filed May 14, 2026 (Form 4/A).
- Sold
- 75,000 shares
- Price
- US$100.12
- Value
- US$7.51M
- Holding after
- 523,478 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 12, 2026 | Common Stock | Option exercise | 75,000 | US$21.58 | 598,478 | Direct |
| May 12, 2026 | Common Stock | Sale | 75,000 | US$100.12 | 523,478 | Direct |
Source
Related
- Protagonist Therapeutics, Inc.
- Patel Dinesh V Ph D
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026
- Form 4 · Patel Dinesh V Ph D · Apr 24, 2026
- Form 4 · Ali Asif · Oct 2, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Waddill William D. · Jun 25, 2026
- Form 4 · Waddill William D. · Jun 11, 2026